Attached files
file | filename |
---|---|
EX-10.40 - EX-10.40 - SANGAMO THERAPEUTICS, INC | d550701dex1040.htm |
EX-31.3 - EX-31.3 - SANGAMO THERAPEUTICS, INC | d550701dex313.htm |
10-K/A - 10-K/A - SANGAMO THERAPEUTICS, INC | d550701d10ka.htm |
Exhibit 31.4
PRINCIPAL FINANCIAL OFFICER CERTIFICATE
I, Kathy Y. Yi, certify that:
1. | I have reviewed this amendment no. 1 to the annual report on Form 10-K of Sangamo Therapeutics, Inc. (the registrant); and |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
Date: April 24, 2018 |
/s/ Kathy Y. Yi |
Kathy Y. Yi |
Executive Vice President and Chief Financial Officer |
(Principal Financial and Accounting Officer) |